Template:Cefdinir: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
ShiSheng (talk | contribs)
nocaptcha
8,707 edits
No edit summary
ShiSheng (talk | contribs)
nocaptcha
8,707 edits
No edit summary
Line 1: Line 1:
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
| style="padding: 0 5px; font-size: 100%; background:#696969" align=center | <span style="color:WHITE;"> '''[[CEFDINIR|CEFDINIR]]'''</span>
| style="padding: 0 5px; font-size: 100%; background:#696969" align=center | <span style="color:WHITE;"> '''[[Cefdinir|Cefdinir]]'''</span>
|-
|-
! style="padding: 0 5px; font-size: 85%; background:WHITE" align=left | FDA Package Insert (OMNICEF<sup>®</sup>)
! style="padding: 0 5px; font-size: 85%; background:WHITE" align=left | FDA Package Insert (OMNICEF<sup>®</sup>)
Line 6: Line 6:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir description|Description]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir clinical pharmacology|Clinical Pharmacology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR microbiology|Microbiology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir microbiology|Microbiology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir indications and usage|Indications and Usage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir contraindications|Contraindications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR warnings|Warnings]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir warnings|Warnings]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR precautions|Precautions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir precautions|Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir adverse reactions|Adverse Reactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir overdosage|Overdosage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR clinical studies|Clinical Studies]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir dosage and administration|Dosage and Administration]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR how supplied|How Supplied]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir how supplied|How Supplied]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[CEFDINIR labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefdinir labels and packages|Labels and Packages]]
|-
|-
|}
|}

Revision as of 16:11, 23 December 2013

Cefdinir
FDA Package Insert (OMNICEF®)
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Compatibility, Reconstitution, and Stability
How Supplied
Labels and Packages
Retrieved from "https://www.wikidoc.org/index.php?title=Template:Cefdinir&oldid=918860"